Literature DB >> 10326054

Relation between experimental and non-experimental study designs. HB vaccines: a case study.

T Jefferson1, V Demicheli.   

Abstract

STUDY
OBJECTIVE: To examine the relation between experimental and non-experimental study design in vaccinology.
DESIGN: Assessment of each study design's capability of testing four aspects of vaccine performance, namely immunogenicity (the capacity to stimulate the immune system), duration of immunity conferred, incidence and seriousness of side effects, and number of infections prevented by vaccination.
SETTING: Experimental and non-experimental studies on hepatitis B (HB) vaccines in the Cochrane Vaccines Field Database.
RESULTS: Experimental and non-experimental vaccine study designs are frequently complementary but some aspects of vaccine quality can only be assessed by one of the types of study. More work needs to be done on the relation between study quality and its significance in terms of effect size.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10326054      PMCID: PMC1756773          DOI: 10.1136/jech.53.1.51

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  9 in total

1.  European Vaccine Manufacturers: present status and future trends.

Authors:  N Baudrihaye
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

2.  Why we need observational studies to evaluate the effectiveness of health care.

Authors:  N Black
Journal:  BMJ       Date:  1996-05-11

3.  New and not so new vaccines.

Authors:  T Jefferson
Journal:  BMJ       Date:  1996-09-28

4.  Global status of hepatitis B immunisation.

Authors:  M A Kane
Journal:  Lancet       Date:  1996-09-14       Impact factor: 79.321

5.  Universal hepatitis B immunization: the British Columbia experience.

Authors:  A Bell
Journal:  Vaccine       Date:  1995       Impact factor: 3.641

6.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials.

Authors:  K F Schulz; I Chalmers; R J Hayes; D G Altman
Journal:  JAMA       Date:  1995-02-01       Impact factor: 56.272

7.  The quest for trials on the efficacy of human vaccines. Results of the handsearch of Vaccine.

Authors:  T Jefferson; V Jefferson
Journal:  Vaccine       Date:  1996-04       Impact factor: 3.641

8.  Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers.

Authors:  R C Wood; K L MacDonald; K E White; C W Hedberg; M Hanson; M T Osterholm
Journal:  JAMA       Date:  1993 Dec 22-29       Impact factor: 56.272

9.  Predictors of hepatitis B vaccine acceptance in health care workers.

Authors:  B N Doebbeling; K J Ferguson; F J Kohout
Journal:  Med Care       Date:  1996-01       Impact factor: 2.983

  9 in total
  6 in total

Review 1.  Demyelinating disease and hepatitis B vaccination: is there a link?

Authors:  T Jefferson; H Heijbel
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 2.  Cochrane reviews and systematic reviews of economic evaluations. Amantadine and rimantadine in the prevention and treatment of influenza.

Authors:  T Jefferson; V Demicheli; D Rivetti; J Deeks
Journal:  Pharmacoeconomics       Date:  1999       Impact factor: 4.981

Review 3.  Vaccines for measles, mumps and rubella in children.

Authors:  Vittorio Demicheli; Alessandro Rivetti; Maria Grazia Debalini; Carlo Di Pietrantonj
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

Review 4.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2021-11-22

Review 5.  Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview.

Authors:  Su Golder; Yoon K Loke; Martin Bland
Journal:  PLoS Med       Date:  2011-05-03       Impact factor: 11.069

6.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2020-04-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.